Evaluation of Cardiotoxicity by Tissue Doppler Imaging in Childhood Leukemia Survivors Treated with Low-Dose Anthracycline
Authors:
- 11 January 2015
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 36 (4) , 862-866
Abstract
Improvement in long-term survival in patients with acute childhood leukemia has led to the need for monitorization of chemotherapy-related morbidity and mortality. This study included 60 patients with acute lymphoblastic leukemia that were in remission for at least 2 years and 30 healthy controls. Systolic and diastolic function of myocardium was evaluated using conventional echocardiography and tissue Doppler imaging of the left ventricle, interventricular septum and right ventricle. Median age of patients was 11.7 years (range 10–14.9 years), and the median duration of remission was 4 years (range 2.5–5 years). All patients were treated with a low cumulative dose of adriamycin (100 mg/m2) according to the St. Jude Total-XIIIA protocol. The ejection fraction (EF) and fractional shortening were normal in the patient and control groups, even though EF values were significantly lower in the patients (69.5 ± 2.3 vs. 72.7 ± 3 %, P < 0.01). Myocardial systole (S m), early diastole (E m) and late diastole (A m) velocities in all segments of the myocardium were significantly lower in the patient group (P < 0.01 for all segments). Cardiotoxicity was noted in all segments of the myocardium in the patient group, despite the fact that they were all treated with a low cumulative dose of adriamycin. Based on these findings, we think that there is no safe dose for anthracyclines and periodic echocardiographic evaluation of both the left and right ventricles must be performed in all patients treated with anthracyclines, even at low doses.Keywords
This publication has 27 references indexed in Scilit:
- The evaluation of doxorubicin-induced cardiotoxicity: Comparison of Doppler and tissue Doppler-derived myocardial performance indexCardiology Journal, 2012
- Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: Retrospective cohort study in a single centre in the United KingdomPediatric Blood & Cancer, 2011
- CARDIAC FUNCTIONS EVALUATED WITH TISSUE DOPPLER IMAGING IN CHILDHOOD CANCERS TREATED WITH ANTHRACYCLINESPediatric Hematology and Oncology, 2010
- Late Effects in Long-Term Survivors After Treatment for Childhood Acute LeukemiaClinical Pediatrics, 2009
- Evaluation of the Left Ventricular Function with Tissue Tracking and Tissue Doppler Echocardiography in Pediatric Malignancy Survivors after Anthracycline TherapyEchocardiography, 2008
- Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology GroupPediatrics, 2008
- Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologiesCardiovascular Ultrasound, 2007
- Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and preventionPediatric Blood & Cancer, 2005
- Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in childrenThe American Journal of Cardiology, 2001
- Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalLeukemia, 2000